GGrantIndex
← Leaderboards

James B Lok

University Of Pennsylvania

$10,713,494
Attributed
$12,777,753
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200621
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$12,777,753 · 7

By mechanism

R01$10,116,317 · 3
R33$1,407,814 · 1
R21$1,253,622 · 3

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Nematoda

Research focus

NematodaParasitesInfectionParasitic NematodeCaenorhabditis ElegansStrongyloides StercoralisTransgenesLifeMolecularPharmaceutical PreparationsSignal TransductionResistanceSignal PathwayLigandsRegulationFundingEnvironmentVaccinesStrongyloidiasisTransgenic OrganismsReceptorBaseMutantIn Vivo

Grant awards (34)

Insulin-like signaling in parasitic nematode development$402,500
R01 · FY2021 · AI · contact PI
Insulin-like signaling in parasitic nematode development$402,500
R01 · FY2020 · AI · contact PI
Using transgenic parasitic nematodes to investigate Type 2 immunity$201,250
R21 · FY2020 · AI
Insulin-like signaling in parasitic nematode development$402,500
R01 · FY2019 · AI · contact PI
Using transgenic parasitic nematodes to investigate Type 2 immunity$241,500
R21 · FY2019 · AI
Mechanisms and Treatment of Chronic, Latent Human Strongyloidiasis$460,951
R33 · FY2017 · AI · contact PI
INSULIN-LIKE SIGNALING IN PARASITIC NEMATODE DEVELOPMENT$400,000
R01 · FY2017 · AI · contact PI
Mechanisms and Treatment of Chronic, Latent Human Strongyloidiasis$469,045
R33 · FY2016 · AI · contact PI
INSULIN-LIKE SIGNALING IN PARASITIC NEMATODE DEVELOPMENT$400,000
R01 · FY2016 · AI · contact PI
Mechanisms and Treatment of Chronic, Latent Human Strongyloidiasis$477,818
R33 · FY2015 · AI · contact PI
INSULIN-LIKE SIGNALING IN PARASITIC NEMATODE DEVELOPMENT$400,000
R01 · FY2015 · AI · contact PI
INSULIN-LIKE SIGNALING IN PARASITIC NEMATODE DEVELOPMENT$400,000
R01 · FY2014 · AI · contact PI
Mechanisms and Treatment of Chronic, Latent Human Strongyloidiasis$227,183
R21 · FY2014 · AI · contact PI
INSULIN-LIKE SIGNALING IN PARASITIC NEMATODE DEVELOPMENT$376,000
R01 · FY2013 · AI · contact PI
Molecular Genetic Tools for Parasitic Helminths$362,760
R01 · FY2013 · AI · contact PI
Mechanisms and Treatment of Chronic, Latent Human Strongyloidiasis$216,689
R21 · FY2013 · AI · contact PI
Molecular Genetic Tools for Parasitic Helminths$385,914
R01 · FY2012 · AI · contact PI
Human Strongyloidiasis: Model Development$385,914
R01 · FY2012 · AI · contact PI
Molecular Genetic Tools for Parasitic Helminths$385,914
R01 · FY2011 · AI · contact PI
Human Strongyloidiasis: Model Development$385,914
R01 · FY2011 · AI · contact PI
Human Strongyloidiasis: Model Development$389,813
R01 · FY2010 · AI · contact PI
Molecular Genetic Tools for Parasitic Helminths$389,813
R01 · FY2010 · AI · contact PI
Insulin-like signaling in parasitic nematode development$371,317
R01 · FY2010 · AI · contact PI
Human Strongyloidiasis: Model Development$393,750
R01 · FY2009 · AI · contact PI
Molecular Genetic Tools for Parasitic Helminths$393,750
R01 · FY2009 · AI · contact PI
Insulin-like signaling in parasitic nematode development$375,067
R01 · FY2009 · AI · contact PI
Human Strongyloidiasis: Model Development$393,750
R01 · FY2008 · AI
Insulin-like signaling in parasitic nematode development$375,067
R01 · FY2008 · AI · contact PI
Insulin-like signaling in parasitic nematode development$382,129
R01 · FY2007 · AI · contact PI
Insulin-like signaling in parasitic nematode development$392,500
R01 · FY2006 · AI · contact PI
Insulin-like Signaling in Parasitic Nematode Development$390,985
R01 · FY2004 · AI
Insulin-like Signaling in Parasitic Nematode Development$390,985
R01 · FY2003 · AI
Insulin-like Signaling in Parasitic Nematode Development$387,475
R01 · FY2002 · AI
REGULTION IN STRONGYLOIDES STERCORALIS$367,000
R21 · FY2000 · AI